{
    "Trade/Device Name(s)": [
        "BLE Smart Blood Glucose Monitoring System",
        "BLE Smart Professional Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K160365",
    "Predicate Device Reference 510(k) Number(s)": [
        "K130181"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "August 31, 2016",
    "Summary Letter Received Date": "September 2, 2016",
    "Submission Date": "August 31, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BLE Smart Meter",
        "BLE Smart Professional Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [
        "In vitro quantitative measurement"
    ],
    "Submission Type(s)": [
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for BLE Smart and BLE Smart Professional Blood Glucose Monitoring Systems with Bluetooth capability for quantitative glucose measurement.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary and venous whole blood from multiple sites; BLE Smart system for single-patient home use, BLE Smart Professional system for multiple-patient use in professional healthcare settings as an aid in monitoring diabetes control.",
    "fda_folder": "Clinical Chemistry"
}